New prognostic biomarker identified in small cell lung cancer

Graphical abstract. Credit: iScience (2024). DOI: 10.1016/j.isci.2024.110413 Small cell lung cancer (SCLC) is a fast-growing and highly malignant subtype of lung cancer. One of the biggest challenges doctors face is the cancer’s resistance to platinum-based chemotherapy, the standard treatment for SCLC patients. Recently, a research group led by Prof. Hong Bo from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences, identified a novel prognostic biomarker that could help predict chemotherapy resistance in SCLC by multi-omics integrative analysis. This finding, published in iScience, could improve treatments for this aggressive form of cancer. In this study, researchers conducted Read More